Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep:117:59-70.
doi: 10.1016/j.neurobiolaging.2022.05.002. Epub 2022 May 13.

Loss of speech and functional impairment in Alzheimer's disease-related primary progressive aphasia: predictive factors of decline

Affiliations

Loss of speech and functional impairment in Alzheimer's disease-related primary progressive aphasia: predictive factors of decline

Salvatore Mazzeo et al. Neurobiol Aging. 2022 Sep.

Abstract

We aimed to identify features associated with different disease trajectories in Alzheimer's disease (AD)-related primary progressive aphasia (PPA). We considered 23 patients diagnosed with AD-related PPA. All patients underwent neuropsychological evaluation, 18F-Fluorodeoxyglucose-PET brain scan, CSF biomarkers measurement and APOE genotype analysis at baseline and underwent neurological follow-up for a mean time of 3 years. Patients who progressed to total loss of speech (TLoS+) had greater impairment in writing and higher t-tau concentration as compared to TLoS- patients. Patients who progressed to loss of functional autonomy (LoFA+) had greater impairment in single-word comprehension as compared to patients who maintained autonomy in self-care. Furthermore, 18F-FDG-PET SPM analyses revealed different brain metabolic patterns between TLoS+ and TLoS- and between LoFA+ and LoFA-. In conclusion, linguistic profile, CSF t-tau and brain metabolic pattern might be useful tools to predict progression to total loss of speech and loss of functional autonomy in AD-related PPA patients.

Keywords: Alzheimer's disease; Amyloid biomarkers; Brain metabolism; Disease progression; Neuropsychology; Primary progressive aphasia.

PubMed Disclaimer

Publication types

MeSH terms

LinkOut - more resources